GSA Capital Partners’s Keros Therapeutics KROS Stock Holding History

GSA Capital Partners’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$400K	Sell
2025 Q2	$820K	Buy
2025 Q1	–	Sell
2024 Q4	$177K	Buy
2024 Q2	–	Sell
2024 Q1	$565K	Buy
2023 Q4	$270K	Sell
2023 Q3	$547K	Buy
2023 Q2	–	Sell
2023 Q1	$782K	Buy
2022 Q4	$392K	Buy